Aclaris Therapeutics (ACRS) Current Leases (2017 - 2023)

Aclaris Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $426000.0 for Q4 2023.

• In Q4 2023, Current Leases fell 37.72% year-over-year to $426000.0; the TTM figure through Dec 2023 stood at $426000.0 (down 37.72% YoY), while the FY2023 annual figure was $426000.0, down 37.72% from the prior year.
• Current Leases was $426000.0 for Q4 2023 at Aclaris Therapeutics, up from $310000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $766000.0 in Q3 2022 to a low of $310000.0 in Q3 2023.
• Historically, Current Leases has averaged $585125.0 across 3 years, with a median of $643500.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Current Leases decreased 1.3% in 2022, then slumped 59.53% in 2023.
• A 3-year view of Current Leases shows it stood at $693000.0 in 2021, then fell by 1.3% to $684000.0 in 2022, then tumbled by 37.72% to $426000.0 in 2023.
• The last three Current Leases figures came in at $426000.0 (Q4 2023), $310000.0 (Q3 2023), and $458000.0 (Q2 2023), per Business Quant data.